Clinical trials
Observational Dysmenorrhea trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 7 |
| Unknown status | 6 |
| Not yet recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 4 |
| Cairo University | 3 |
| Oslo University Hospital | 3 |
| Kanuni Sultan Suleyman Training and Research Hospital | 2 |
| AbbVie | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Ankara Yildirim Beyazıt University | 1 |
| Assiut University | 1 |
| Başakşehir Çam & Sakura City Hospital | 1 |
| Beni-Suef University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dysmenorrhea | 48 |
| Endometriosis | 11 |
| Menorrhagia | 9 |
| Pelvic Pain | 9 |
| Adenomyosis | 7 |
| Dyspareunia | 6 |
| Infertility | 6 |
| Metrorrhagia | 5 |
| Pain | 3 |
| Chronic Pain | 2 |
Trials
Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.